Signalife Receives FDA Clearance for OTC Non-Prescription Event Recorder Device

Signalife, Inc. (AMEX:SGN)(AMEX:-)(AMEX:News) has received FDA 510(k) clearance to market and sell - without prescription - its ambulatory event recorder throughout the United States. This device, which Signalife will market as the Fidelity 200 HeartLife Tempo Card, is a direct-to-consumer non-prescription flexible credit card- sized heart monitoring device which will be used as an early-detection device by patients who desire to independently monitor their condition. The HeartLife Tempo Card uses the award-winning amplification technology contained in Signalife's Fidelity 100 Heart Monitor. In operation, at the onset of an event that will be recorded, the patient will hold the event...

Want to see the full article?

• Purchase this article for only $3.00